Premier Health of America Future Growth
Future criteria checks 0/6
Premier Health of America is forecast to grow revenue at 2.1% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 57.7% |
| Revenue growth rate | 2.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 11 Dec 2024 |
Recent future growth updates
Recent updates
Is Premier Health of America (CVE:PHA) Using Too Much Debt?
Dec 12
Does Premier Health of America (CVE:PHA) Have A Healthy Balance Sheet?
Aug 20Investors Aren't Entirely Convinced By Premier Health of America Inc.'s (CVE:PHA) Revenues
Jun 27Premier Health of America (CVE:PHA) Has A Somewhat Strained Balance Sheet
May 02A Piece Of The Puzzle Missing From Premier Health of America Inc.'s (CVE:PHA) 30% Share Price Climb
Feb 14Further Upside For Premier Health of America Inc. (CVE:PHA) Shares Could Introduce Price Risks After 26% Bounce
Dec 28Here's Why Premier Health of America (CVE:PHA) Has A Meaningful Debt Burden
Dec 12These 4 Measures Indicate That Premier Health of America (CVE:PHA) Is Using Debt Extensively
Jul 06Does Premier Health of America (CVE:PHA) Have A Healthy Balance Sheet?
Jul 31We Think Premier Health of America (CVE:PHA) Can Stay On Top Of Its Debt
Apr 09Here's Why Premier Health of America (CVE:PHA) Can Manage Its Debt Responsibly
Dec 24Estimating The Intrinsic Value Of Premier Health of America Inc. (CVE:PHA)
Oct 29Investors Shouldn't Be Too Comfortable With Premier Health of America's (CVE:PHA) Robust Earnings
May 28Independent Chairman of the Board Eric Chouinard Just Bought 9.4% More Shares In Premier Health of America Inc. (CVE:PHA)
Feb 23These 4 Measures Indicate That Premier Health of America (CVE:PHA) Is Using Debt Reasonably Well
Feb 08Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2027 | 166 | N/A | N/A | N/A | 1 |
| 9/30/2026 | 157 | N/A | N/A | N/A | 1 |
| 9/30/2025 | 149 | N/A | N/A | N/A | 1 |
| 9/30/2024 | 158 | -12 | 3 | 6 | N/A |
| 6/30/2024 | 148 | -12 | -1 | 2 | N/A |
| 3/31/2024 | 130 | -3 | 7 | 9 | N/A |
| 12/31/2023 | 106 | -2 | 1 | 3 | N/A |
| 9/30/2023 | 90 | -2 | -3 | -1 | N/A |
| 6/30/2023 | 89 | 0 | -6 | -4 | N/A |
| 3/31/2023 | 88 | 0 | -7 | -6 | N/A |
| 12/31/2022 | 84 | -1 | -7 | -6 | N/A |
| 9/30/2022 | 81 | 0 | 3 | 4 | N/A |
| 6/30/2022 | 76 | 1 | 4 | 6 | N/A |
| 3/31/2022 | 72 | 0 | 3 | 5 | N/A |
| 12/31/2021 | 72 | 1 | 4 | 6 | N/A |
| 9/30/2021 | 67 | 1 | 0 | 2 | N/A |
| 6/30/2021 | 56 | 1 | 1 | 2 | N/A |
| 3/31/2021 | 43 | 1 | 1 | 2 | N/A |
| 12/31/2020 | 31 | 0 | -1 | 0 | N/A |
| 9/30/2020 | 21 | 0 | 0 | 1 | N/A |
| 6/30/2020 | 17 | 0 | 1 | 1 | N/A |
| 3/31/2020 | 14 | 0 | 0 | 0 | N/A |
| 12/31/2019 | 15 | 1 | 0 | 0 | N/A |
| 9/30/2019 | 12 | 0 | 0 | 0 | N/A |
| 6/30/2019 | 11 | 1 | 0 | 1 | N/A |
| 9/30/2018 | 8 | 0 | 0 | 0 | N/A |
| 9/30/2017 | 6 | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if PHA's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if PHA's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if PHA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: PHA's revenue (2.1% per year) is forecast to grow slower than the Canadian market (7.1% per year).
High Growth Revenue: PHA's revenue (2.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PHA's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/15 06:57 |
| End of Day Share Price | 2025/01/15 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Premier Health of America Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jim Byrne | Acumen Capital Finance Partners Limited |
| Douglas Loe | Leede Jones Gable Inc |